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During primary infection, murine cytomegalovirus
(MCMV) spreads systemically, resulting in virus repli-
cation and pathology in multiple organs. This
disseminated infection is ultimately controlled, but
the underlying immune defense mechanisms are
unclear. Investigating the role of the cytokine IL-22
in MCMV infection, we discovered an unanticipated
function for neutrophils as potent antiviral effector
cells that restrict viral replication and associated
pathogenesis in peripheral organs. NK-, NKT-, and
T cell-secreted IL-22 orchestrated antiviral neutro-
phil-mediated responses via induction in stromal
nonhematopoietic tissue of the neutrophil-recruiting
chemokine CXCL1. The antiviral effector properties
of infiltrating neutrophils were directly linked to the
expression of TNF-related apoptosis-inducing ligand
(TRAIL). Our data identify a role for neutrophils in
antiviral defense, and establish a functional link
between IL-22 and the control of antiviral neutrophil
responses that prevents pathogenic herpesvirus
infection in peripheral organs.
INTRODUCTION
During acute infection, pathogenic viruses target numerous or-
gans to facilitate replication and dissemination. Themechanisms
of organ-specific control of virus infection are poorly understood.
The b-herpesvirus murine cytomegalovirus (MCMV) has co-
evolved with its mammalian host over millions of years, providing
a paradigm of a well-adapted persistent virus that has been
extensively exploited in studies of host-pathogen interactions
in vivo. MCMV also provides the most tractable in vivo model
for the pathogenic b-herpesvirus human cytomegalovirus
(HCMV), exhibiting many parallels in terms of pathogenesis,
host immunity, immune evasion, and broad tissue tropism (Shel-Celllam et al., 2006). NK cells are a key component of the innate im-
mune response and are critical for the control of human herpes-
viruses, a control that has been elegantly modeled in MCMV
(Biron et al., 1989; Bukowski et al., 1984). Importantly, however,
the antiviral role of NK cells can be both cell-type and organ
specific. For example, NK cell depletion preferentially increases
MCMV progeny derived from endothelial cells as compared with
nonendothelial cell-derived virus, and this effect is more pro-
found in the lung versus other sites of infection (Sacher et al.,
2012). Moreover, NK cells in the salivary gland, which represents
a key site of MCMV persistence and dissemination, are hypores-
ponsive to MCMV infection (Tessmer et al., 2011).
Studies in MCMV also highlight the pivotal role for cytokines
such as type I interferons (IFNab), lymphotoxin, IL-12, and
IL-18 in either inhibiting viral replication directly or regulating
the development of innate and adaptive immunity (Andoniou
et al., 2005; Andrews et al., 2003; Banks et al., 2005; Orange
and Biron, 1996). However, restricted expression of such
cytokines in MCMV-infected tissues is observed (Schneider
et al., 2008). Collectively, these data are consistent with the
existence of additional antiviral effector mechanisms that
counter CMV in a broad range of cells within a plethora of tissue
microenvironments.
Interleukin-22 (IL-22) is an important effector cytokine in
peripheral tissues. IL-22 is expressed by numerous innate and
adaptive immune cells and signals through the IL-22Ra/IL-
10Rb dimeric receptor (Sonnenberg et al., 2011). While IL-
10Rb is ubiquitously expressed, IL-22Ra expression is restricted
to nonhematapoetic cells, with elevated expression in tissues
such as the oral/gastrointestinal tract, lung, skin, kidney, and
liver (Wolk et al., 2004).
IL-22 contributes to the immune control of gram-negative
bacterial infections at mucosal surfaces while also exhibiting
tissue-protective functions (Aujla et al., 2008; Zenewicz et al.,
2007; Zheng et al., 2008). The role of IL-22 in viral infections is
less well defined. IL-22 neutralization does not impair protection
from influenza infection in mice (Guo and Topham, 2010) and, in
certain viral infection models, can heighten inflammation without
influencing virus clearance (Zhang et al., 2011). In contrast, IL-22
is cytoprotective in the liver during arenavirus chronicityHost & Microbe 15, 471–483, April 9, 2014 ª2014 The Authors 471
Figure 1. IL-22 Limits Acute MCMV Replication in a Tissue-
Restricted Manner
(A) IL-22R gene expression in the liver, lungs, and spleens of naive (day 0) and
MCMV-infected mice day 2 p.i.
(B–D) Replicating virus in livers (B), lungs (C), and spleens (D) of mice infected
for 2 (triangles) and 4 (circles) days and treated with IgG or aIL-22. Results are
expressed as PFU/g tissue. Individual mice + median values are shown.
Dotted line, limit of detection (LD).
(E) Weight loss is expressed as mean ± SEM (6 mice/group) of percent of
starting weight. Data represent two to six experiments. See also Figure S1.
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IL-22 Promotes Antiviral Neutrophil Responses(Pellegrini et al., 2011). CD161+ T cells that express IL-22 are
enriched in the liver during chronic hepatitis C virus (HCV) infec-
tion (Billerbeck et al., 2010; Kang et al., 2012), and the single
nucleotide polymorphism IL-22-rs1012356 SNP is associated
with protection from HCV (Hennig et al., 2007). IL-22 has also
been implicated in direct inhibition of dengue virus replication472 Cell Host & Microbe 15, 471–483, April 9, 2014 ª2014 The Autho(Guabiraba et al., 2013) and T cell-mediated protection from
horizontal HIV transmission (Misse´ et al., 2007). Consequently,
a consensus is beginning to emerge that IL-22may exert antiviral
control during infection.
To investigate this, we utilized the MCMV model to elucidate
the role that IL-22 plays in viral infection of peripheral tissue.
Our results reveal a previously unanticipated mechanism
through which IL-22 impacts on virus-induced immune re-
sponses and a potent effector mechanism that counters herpes-
virus infection.
RESULTS
IL-22 Affords Tissue-Restricted Protection from MCMV
Infection
During primary infection, MCMV targets multiple organs of the
secondary lymphoid tissue (e.g., spleen), mucosa (e.g., lung),
and nonmucosa (e.g., liver). IL-22RmRNA is expressed predom-
inantly in barrier surfaces and also in the liver (Wolk et al., 2004).
In accordance, IL-22R was expressed in murine lung and liver,
and expression was further elevated in the liver and, to a lesser
extent, the lung in response to MCMV (Figure 1A). No significant
IL-22R expression was detected in the spleen before or after
MCMV infection (Figure 1A). Histological analysis of mice
expressing LacZ under the control of the Il-22ra1 promoter
demonstrated IL-22R expression within the lung, particularly
by epithelial cells (see Figure S1 available online). Moreover,
IL-22R expression by cells with large nuclei, indicative of hepa-
tocytes, was detectable throughout the liver (Figure S1).
Given that IL-22R was expressed in mucosal and hepatic sites
targeted by MCMV, we hypothesized that IL-22 influenced the
outcome of acute infection. To test this, MCMV-infected mice
were treated with either an IL-22-blocking antibody (aIL-22) or
IgG control. IL-22 neutralization markedly increased infectious
virus load in the liver as early as 2 days after infection (Figure 1B).
In the lung, low levels of virus infection occur within the first
2 days of infection, as demonstrated by detection of infectious
virus in only four of ten IgG-treated mice (Figure 1C). After
aIL-22 treatment, however, virus was detected in eight of ten
lungs, seven of which demonstrated higher virus load than
IgG-treated mice (Figure 1C), highlighting an antiviral function
for IL-22 during initial infection and suggesting it sets a threshold
for acute virus replication in the lung. Consistent with low IL-22R
expression in the spleen (Figure 1A), IL-22 neutralization did not
influence virus replication in this organ (Figure 1D). Despite this
tissue-restricted antiviral role for IL-22, the global effect of
IL-22 was demonstrated by exacerbated weight loss in aIL-22-
treated mice (Figure 1E). Thus, IL-22 limits MCMV infection in
an organ-specific manner that is determined by IL-22R expres-
sion, and restricts clinical signs of virus-induced disease.
Conventional NK Cells, NK T Cells, and T Cells Are
Significant Sources of IL-22 in MCMV Infection
MCMV infection enhanced IL-22 production in the liver and lung
(Figure 2A). Conventional NK1.1+ NK cells and NK T cells secrete
IL-22 in virus infections (Guo and Topham, 2010; Juno et al.,
2012; Kumar et al., 2013), and NK1.1 depletion during MCMV
infection abrogated IL-22 protein production in the liver and
lung (Figure 2A). Furthermore, T cells produce IL-22 in certainrs
Figure 2. Conventional NK Cells, NK T Cells, and ab T Cells Express IL-22 during MCMV Infection
(A–C) Mice were infected with MCMV or mock infected (naive), and day 4 p.i. liver (left) and lung (right) tissue was isolated. (A) IL-22 protein concentrations within
organ homogenates from naive mice, MCMV-infected mice (day 4 p.i.) treated with IgG, aNK1.1, or aCD4 and aCD8. (B and C) The proportion (B) and total
numbers (C) of IL-22+ cells in naive and infected (day 4 p.i.) organs were assessed by FACS. Results showmean ± SEMof four to sevenmice/group and represent
two (A) or six (B and C) experiments studying expression at either day 2 or day 4 p.i.
(D) Representative bivariate flow cytometry plots of IL-22 versus NK1.1 expression by hepatic NK1.1+CD3+ cells from WT (left and middle) or IL-22/mice day
0 or day 4 p.i., measured after 4 hr stimulation with PMA/ionomycin.
(E) Expression of RORgT by NK1.1+CD3IL-22+ cells derived from the Peyer’s patch (PP), liver and lung, and splenic CD3+ cells from naive mice.
(F) Representative histogram overlays of surface marker expression by IL-22+ (solid line) and IL-22 (dotted line) pulmonary NK cells day 0 and day 4 p.i. Results
representR3 experiments. See also Figure S2.
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and CD8+ cells (which includes CD4+ NK T cells) also reduced
IL-22 production (Figure 2A). NK1.1 or CD4/CD8 depletion
reduced IL-22 protein concentrations below those detected in
naive tissue. This may reflect higher IL-22 turnover upon infec-
tion due to increased IL-22R expression (Figure 1A) and/orCellpossible secretion of IL-22 binding protein that, after depletion
of IL-22+ cells, reduced detectable soluble IL-22 below levels
measured in naive tissue.
In accordance with the hypothesis that NK cells, NK T cells,
and CD4+ and CD8+ ab T cells produce IL-22, analysis of cyto-
kine secretion by leukocytes following ex vivo stimulation withHost & Microbe 15, 471–483, April 9, 2014 ª2014 The Authors 473
(legend on next page)
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IL-22 Promotes Antiviral Neutrophil ResponsesPMA/ionomycin and IL-23 identified NK cells (Figures 2B–2E,
S2A, and S2B), CD4+CD3+, and CD8+CD3+ (Figures 2B, 2C,
S2A, and S2C) to be significant IL-22+ cells in the liver and
lung, and NK T cells (NK1.1+CD3+) also representing a significant
hepatic IL-22-secreting cell (Figures 2B and 2C). NK cells were
the predominant IL-22+ cell-type at day 2 (Figure S2A) and day
4 p.i. (Figures 2B and 2C). Thus, NK1.1+ cells and T cells repre-
sent the major IL-22-producing cells in tissues where IL-22 re-
stricts MCMV.
Phenotypic characterization of NK cells demonstrated that,
unlike NKp46+CD3 IL-22 producing innate lymphoid cells
(ILCs) of the gastrointestinal tract (Satoh-Takayama et al.,
2008), IL-22+ NK cells in the liver and lung did not express
RORgT (Figure 2E). Moreover, pulmonary and hepatic IL-22+
NK cells expressed granzyme B, many of which coexpressed
IFN-g, suggesting conventional NK cell function (Figure S2D).
Indeed, a significant proportion of IL-22+ NK cells coexpressed
CD27 and CD11b (Figures S2E and S2F), indicating high cyto-
toxic capacity (Hayakawa and Smyth, 2006). Addition of IL-23,
the receptor for which is not expressed by conventional NK cells
(Cohen et al., 2013), did not increase IL-22+ NK cell frequency
detected after incubation with PMA/ionomycin (Figure S2G).
Also, IL-22+ NK cells expressed markers of conventional NK
cells but not a marker of ILCs, CD127 (Figures 2F, S2E, and
S2F). IL-22+ (and IL-22) NK cells upregulated the activation
marker CD69 upon infection (Figures 2F and S2F). Interestingly,
IL-22+ and IL-22 NK cells expressed comparable levels of the
activating receptor Ly49H, suggesting the development of
IL-22+ NK cells was not influenced by Ly49H activation.
IL-22 Promotes Accumulation of Neutrophils in
Peripheral Tissue
The mechanisms through which IL-22 exerted antiviral control
were next investigated. Preincubation of an IL-22R-expressing
epithelial cell line (SGC1) with IL-22 did not inhibit MCMV replica-
tion (data not shown). Moreover, aIL-22 did not influence antiviral
IFN (type I and II), lymphotoxin, TNF-a, IL-18, IL-1b, or IL-6
expression, nor did it influence serum amyloid A (SAA) secretion
in livers and lungs day 2 p.i. (data not shown); the time point at
which IL-22 first displayed antiviral activity. NK cell accumulation
and ex vivo degranulation and IFN-g expression in the lung
and liver were unaltered after aIL-22 treatment (data not shown).
Moreover, macrophage and monocyte accumulation within
MCMV-infected organs was unaffected by aIL-22 treatment
(Figures 3A–3C).
Strikingly, however, accumulation of neutrophils, which repre-
sented a substantial proportion of the MCMV-elicited leukocyte
infiltrate in the liver (Figure 3D) and lung (Figure 3E) 2 days p.i.,
was substantially reduced in both organs after IL-22 neutraliza-Figure 3. IL-22 Neutralization Impairs Neutrophil Recruitment into MC
MCMV-infectedmicewere administered IgG or aIL-22 and leukocyte infiltrates (A–
numbers in liver (A), lung (B), and spleen (C) were quantified and are shown asmea
neutrophils in the liver (D), lung (E), and spleen (F). Results represent three exp
neutrophil (Ly6G+CD11b+) recruitment into the liver (G), lung (H), and spleen (I) as
from two independent experiments combined. (J) 3T3 (IL-22R) and SGC1 (IL-22
alone prior to MCMV infection (moi 0.5). Supernatants were then assayed for CXC
four experiments. (K–M) CXCL1 protein in liver (K), lung (L), and spleen (M) homoge
ten (MCMV infected ± aIL-22) mice is shown. Results are combined from two ind
Celltion (Figures 3A, 3B, 3D, and 3E). In the spleen, however,
aIL-22 did not influence neutrophil accumulation in this IL-22-
refractory site (Figures 3C and 3F).
Murine CXCL1 (KC) is the main neutrophil-activating chemo-
kine (Sadik et al., 2011), and in vivo administration of an aCXCL1
neutralizing antibody restricted neutrophil accumulation in the
liver (Figure 3G) and lung (Figure 3H). In contrast, aCXCL1
increased neutrophil accumulation in the spleen (Figure 3I),
consistent with the hypothesis that neutrophil migration into
the lung and liver is controlled by different mechanisms to those
in the spleen. IL-22 induced secretion of CXCL1 by IL-22R+
SGC1 cells by 6 hr poststimulation (Figure 3J), and crucially,
aIL-22 reduced CXCL1 protein concentrations in the liver
(Figure 3K) and lung (Figure 3L) 2 days p.i., suggesting that early
induction of CXCL1 secretion by IL-22 is critical for chemokine-
driven neutrophil recruitment. Consistent with the low IL-22R
expression in the spleen (Figure 1A), aIL-22 did not influence
CXCL1 secretion in this organ (Figure 3M).
Neutrophils Afford Protection from MCMV Replication
In Vivo
The association between the tissue-restricted antiviral activity
of IL-22 and neutrophil infiltration implied an antiviral function
for this cell population. Upon MCMV infection, neutrophils
were detected in high numbers in infected tissues (Figures 3A–
3C), and a high frequency of activated CD11b+ cells was present
in these infected organs (Figure 4A), demonstrating that these
cells were activated during MCMV infection. Furthermore, histo-
logical analysis of MCMV-infected tissue demonstrated that
neutrophils localized adjacent to infected cells (Figure 4B).
To test whether neutrophils contributed to antiviral immunity,
MCMV-infected mice were administered with a Ly6G-specific
monoclonal antibody that specifically depleted neutrophils
without affecting inflammatory monocyte/macrophage popula-
tions (Figure 5A). Strikingly, antibody-mediated depletion of
neutrophils increased MCMV-induced weight loss (Figure 5B).
This exacerbation of virus-induced illness was associated with
elevated virus load in liver (Figure 5C) and lungs (Figure 5D),
but not the spleen (Figure 5E).
C57BL/6 mice lacking adaptive immunity control acuteMCMV
infection, a process mediated in part by Ly49H-expressing NK
cells recognizing MCMV m157 protein (French et al., 2004).
Strikingly, we observed that depletion of neutrophils in MCMV-
infected RAG/mice triggered dramatic weight loss (Figure 5F)
and a concurrent large elevation in replicating virus in the livers
(Figure 5G) and lungs (Figure 5H). Interestingly, in this model
where 14% of splenocytes prior to MCMV infection are
Ly6G+ neutrophils, depletion of these cells also increased repli-
cating virus detected in the spleen (Figure 5I). Thus, neutrophilsMV-Infected Tissues
F) and chemokine protein expression (K–M) assessed after 2 days.Myeloid cell
n ± SEM of six mice per group. Representative bivariate plots of Ly6G+CD11b+
eriments. (G–I) MCMV-infected mice were treated with IgG or aCXCL1 and
sessed by FACS. Results are expressed as mean + SEM of 11 mice, with data
R+) cells were incubated for 6 hr in medium alone, 50 ng/ml rIL-22, or medium
L1 protein. Data are shown as mean + SEM of duplicate samples, representing
nates from IgG- or aIL-22-treatedmice day 2 p.i. Mean + SEMof eight (naive) or
ependent experiments, representing four in total.
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Figure 4. Neutrophil Recruitment into MCMV-Infected Organs
(A) CD11b expression by pulmonary (top) and splenic (bottom) neutrophils in
infected (day 2 p.i.) or mock-infected mice.
(B) Neutrophil localization near MCMV-infected (m123+) cells in the liver was
visualized in hematoxylin-stained paraffin-embedded sections. Liver sections
from mock-infected tissues (103, top left) were used as negative controls for
am123 (brown) and aLy6G (purple) staining. Infected tissue is shown at 103
magnification (bottom left) and 603 (top and bottom right). All images are
taken from different mice, representing <8. Arrow, MCMV-infected m123+
nucleus; triangle, neutrophil. Bars, 100 mM (103 magnification), 20 mM (603
magnification).
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in vivo.
Neutrophils Directly Inhibit MCMV Replication
We characterized the mechanistic control of MCMV by neutro-
phils. Neutrophil crosstalk with NK cells promotes NK cell devel-
opment, including enhanced NK cell cytotoxicity (Jaeger et al.,
2012). However, as mentioned earlier, the accumulation of cyto-
toxic NK cells was not affected by aIL-22 (data not shown), and
neutrophil depletion did not impair NK cell accumulation, cyto-
toxicity or IFN-g expression (Figure S3). Furthermore, concurrent
depletion of both neutrophils and NK cells exhibited an additive
antagonistic effect on host control of infection (Figure 6A). Of
note, NK depletion did not influence neutrophil accumulation in
infected tissues (data not shown). Taken with the observations476 Cell Host & Microbe 15, 471–483, April 9, 2014 ª2014 The Authothat T cells secrete IL-22 (Figures 2A–2C) and that MCMV repli-
cation (which is elevated after NK1.1 depletion in this model
[Stacey et al., 2011]) directly induces CXCL1 production (Fig-
ure 3J), these results demonstrate that NK1.1 cells are capable
of promoting neutrophil recruitment in the absence of NK cells.
Importantly, these results also imply that neutrophil activation
of NK cells is not the primary mechanism through which neutro-
phils control MCMV.
We investigated whether neutrophils were capable of direct
antiviral activity. Coincubation of purified neutrophils (Figure 6B)
with 3T3 fibroblasts led to 50% neutrophil viability for up to
72 hr and, interestingly, we observed a trend in elevated neutro-
phil viability following coincubation with MCMV-infected cells
(Figure 6C). Crucially, neutrophil coincubation with MCMV-
infected fibroblasts dramatically reduced the production of repli-
cative virions in a cell-number-dependent manner (Figure 6D),
demonstrating that neutrophils directly inhibit MCMV replication.
Neutrophils Exert Anti-MCMV Activity in a TRAIL-
Dependent Manner
To identify the mechanism(s) through which neutrophils exert
antiviral activity, expression of putative antiviral effector mole-
cules by hepatic neutrophils isolated 2 days p.i. was measured.
We detected no expression of type I and II interferons, perforin,
and lymphotoxin by MCMV-induced neutrophils (Figure S4A).
However, MCMV-induced neutrophils expressed significant
iNOS, TNF-a, TRAIL, and low but reproducibly detectable FasL
mRNA (Figure S4A). Gene expression analysis in whole tissue
revealed that all four genes were upregulated uponMCMV infec-
tion in vivo (Figure 7A).
The effect of antagonizing each of these molecules on antiviral
neutrophil activity was next assessed. Strikingly, inhibition of the
death receptor ligand TRAIL dramatically abrogated the antiviral
activity of neutrophils (Figure 7B) without influencing neutrophil
survival (Figure S4B). In addition, FasL blockade moderately
antagonized neutrophil-mediated control of MCMV, although
this was not statistically significant (Figure 7B). Further, soluble
TRAIL (Figure 7C) and, to a lesser extent, soluble FasL (Figure 7D)
inhibited MCMV replication, further implying a dominant role
for TRAIL in facilitating neutrophil-mediated antiviral control.
Indeed, TRAILR (DR5) was upregulated byMCMV-infected fibro-
blasts in vitro 6 hr p.i., although expression was downregulated
by 24 hr with complete reversal of TRAILR expression by 48 hr
(Figure 7E). In contrast, we observed no significant regulation
of Fas by MCMV (data not shown). Collectively, these results
pointed toward a dominant role for TRAIL in the anti-MCMV func-
tion of neutrophils and are consistent with the observation that
CMVs actively downregulate surface TRAILR expression (Smith
et al., 2013). Furthermore, in accordance with complete down-
regulation of TRAILR expression by 48 hr, delaying the addition
of neutrophils (Figure 7F) or soluble TRAIL (Figure S4C) to
MCMV-infected fibroblasts until this time point abrogated anti-
viral activity.
We next investigated whether TRAIL expression by neutro-
phils contributed to antiviral control in vivo. In accordance with
infection-induced TRAIL mRNA expression (Figure 7A), MCMV
induced cell-surface TRAIL expression by neutrophils (Fig-
ure 7G). We inhibited TRAIL/TRAILR interactions in vivo with
blocking aTRAIL antibody in NK-depleted RAG/ mice, thusrs
Figure 5. Neutrophil Depletion Impairs Control of Acute MCMV Infection
MCMV-infected and mock-infected C57BL/6 (A–E) or RAG1/ (F–I) mice were treated with aLy6G or IgG. (A) Representative bivariate plots demonstrating
specific depletion of neutrophils (Ly6BintGr1hi) in lungs and livers with aLy6G antibody. (B) Weight loss in MCMV-infected and mock-infected IgG- and aLy6G-
treated mice is expressed as percentage of original weight and is shown as mean ± SEM of ten mice per infected group and three mice per naive group.
Replicating virus in livers (C), lungs (D), and spleens (E) 4 days p.i. in IgG- and aLy6G-treated mice is shown as individual mice + median. All data represent five
independent experiments. (F–I) MCMV-infectedRAG1/mice were treated with IgG or aLy6G. (F) Weight loss is expressed as percentage of original weight and
is shown asmean ± SEMof fivemice per group, representing two experiments. (G–I) Replicating virus in homogenates from the livers (G), lungs (H), and spleens (I)
4 days p.i. in IgG- and anti-Ly6G-treated RAG/ mice. Individual mice + median from two experiments are shown.
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responsiveness observed in TRAILR/ mice (Diehl et al.,
2004) and in aTRAIL-treated RAG/ mice (data not shown).
AlthoughNK cell depletion impairs leukocyte recruitment in livers
of RAG/ mice (Salazar-Mather et al., 1998), Ly6G depletionCellexperiments demonstrated that neutrophils clearly exerted anti-
viral control (Figure 7H). Importantly, TRAIL blockade increased
MCMV burden to comparable levels measured in neutrophil-
depleted mice (Figure 7H). Critically, antagonizing both TRAIL
and neutrophils did not further abrogate antiviral protectionHost & Microbe 15, 471–483, April 9, 2014 ª2014 The Authors 477
Figure 6. Neutrophils Limit MCMV Replication In Vitro
(A) MCMV-infected mice were treated ± aLy6G ± aNK1.1, and day 4 p.i. virus
load wasmeasured by plaque assay. Data from two experiments +median are
shown.
(B–D) Neutrophil purity was assessed by FACS (B), and survival following
incubation with mock-infected and MCMV-infected fibroblasts was assessed
with Annexin V and live/dead aqua (C). (D) Replicating virus in supernatants
from neutrophil/fibroblast cocultures was measured after 7 days. Some wells
received freeze-thawed neutrophils as negative controls. Data represent three
(A), two (C), and four (B and D) experiments. See also Figure S3.
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478 Cell Host & Microbe 15, 471–483, April 9, 2014 ª2014 The Autho(Figure 7H), providing evidence that neutrophils limit MCMV
replication in vivo via TRAIL. Finally, neutralization of IL-22 in
neutrophil-depleted WT mice failed to further increase virus
load as compared to aLy6G treatment alone, suggesting that
IL-22 exerts antiviral control via neutrophil recruitment (Figure 7I).
Consistent with this hypothesis, IL-22 neutralization, which
resulted in an 2-fold reduction in neutrophil recruitment, had
a lesser impact on antiviral control than Ly6G depletion (Fig-
ure 7I). Collectively, these results demonstrate that IL-22 drives
antiviral neutrophil response in vivo, and that TRAIL is a signifi-
cant mechanism through which neutrophils restrict MCMV
replication.
DISCUSSION
We identified neutrophils as potent antiviral effector cells that
restrict CMV infection of peripheral tissue and exert antiviral
activity via TRAIL. In addition, we identified IL-22 as an important
component of the antiviral immune response that recruits
neutrophils to peripheral sites of MCMV infection in which IL-
22R is expressed. Thus, the IL-22-neutrophil axis represents a
pathway that counteracts virus invasion of peripheral tissues.
The role that neutrophils play in viral infections is not well
appreciated. Depletion of Ly6G+ cells during influenza infection
revealed that neutrophils limit influenza-induced illness, although
it is not clear whether neutrophils directly impinge on virus repli-
cation (Tate et al., 2009, 2011). Paradoxically, neutrophils are
associated with influenza-induced inflammation (La Gruta
et al., 2007), particularly during infection with highly pathogenic
strains (Perrone et al., 2008). In contrast to MCMV, neutrophils
support West Nile virus replication, while depletion experiments
suggested that neutrophils exert antiviral control during later
stages of acute infection (Bai et al., 2010). Moreover, neutrophil
extracellular traps capture HIV and promote virus killing via mye-
loperoxidase and a-defensin (Saitoh et al., 2012) and limit
poxvirus infection in vivo (Jenne et al., 2013). Neutrophils also
kill HIV-infected CD4+ T cells via antibody-dependent cellular
cytotoxicity (Smalls-Mantey et al., 2013). Intriguingly, in the
context of herpesviruses, neutropenia has been identified as a
risk factor for occurrence of herpesvirus infections in immune-
suppressed individuals (Jang et al., 2012; Lee et al., 2012).
Importantly, depletion in mice of cells expressing Gr1, which is
expressed by numerous cells including Ly6G+ neutrophils (Tate
et al., 2009), elevates HSV replication in the genital mucosa (Milli-
gan, 1999) and cornea (Tumpey et al., 1996). We now provide
definitive evidence that neutrophils directly inhibit replication of
a pathogenic herpesvirus in vitro and in vivo.
Expression of TRAIL is one mechanism through which neutro-
phils exert direct antiviral activity in vitro and in vivo. Neutrophilsrs
Figure 7. Neutrophils Limit MCMV Replica-
tion in a TRAIL-Dependent Manner
(A) Whole-tissue gene expression in naive and
infected (day 2 p.i.) livers. (B) Purified neutrophils
were added or not at a ratio of 1:1 neu-
trophils:infected fibroblast ± antagonists of poten-
tial antiviral effector molecules. Relative reduction
in MCMV PFU was compared between medium
control and experimental groups. (C and D) In-
fected fibroblasts were incubatedwith recombinant
TRAIL (C) or recombinant FasL (D) and replicating
virus measured after 7 days. (E) Fibroblasts were
MCMV infected (moi 0.2), and TRAILR expression
was measured by FACS. Shaded, FMO; dotted
lines, mock infected; solid line, MCMV infected. (F)
Purified neutrophils were added or not to MCMV-
infected fibroblasts 0, 24, or 48 hr p.i. and virus
measured 7 days later. Data are shown as mean +
SEM of four replicates. (G) Representative bivariant
FACS plots of surface TRAIL expression by liver
neutrophils. FMO, fluorescenceminus one; positive
control, NK1.1+CD3 cells from naive livers of 3-
week-old mice. (H) MCMV-infected RAG/ mice
were depleted of NK1.1 cells and administered IgG
(C), aLy6G (B), aTRAIL (-) or aLy6G and aTRAIL
(,), and hepatic virus load was measured at day 4
p.i. (I) MCMV-infected C57BL/6 mice were admin-
istered IgG (C), aIL-22 (B), aLy6G (-), or aIL-22
and aLy6G (,) and virus load in liver tissue
measured 4 days p.i. Results represent two (A, C,
D, F, and G) or three (B and E) independent ex-
periments, or show data merged from two experi-
ments (H and I). See also Figure S4.
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not preclude the possibility that neutrophils also secrete TRAIL
in response to MCMV. HCMV UL141 protein promotes intra-
cellular retention of TRAIL receptors, desensitizing cells to
TRAIL-mediated apoptosis (Smith et al., 2013). We observed
TRAILR downregulation in MCMV-infected fibroblasts, consis-
tent with the role of MCMV m166 protein in restricting TRAILR
expression (C.A.B, unpublished data). Abrogation of neutrophil-
and TRAIL-mediated inhibition of MCMV replication after 24 hr
suggests neutrophils limit virus replication within the first hours
of infection when TRAILR is present on the cell surface. TRAILR
downregulation implies viral evasion of TRAIL-induced cell
death. However, TRAILR signaling also induces NF-kB-Cell Host & Microbe 15, 471mediated proinflammatory cytokine pro-
duction (Tang et al., 2009), suggesting
that TRAIL may induce multiple antiviral
pathways. Incomplete reversal of neu-
trophil antiviral activity following TRAIL
inhibition suggests additional mecha-
nisms exist through which neutrophils
restrict MCMV. Neutrophil exposure to
MCMV or infected cells did not upregulate
reactive oxygen species (data not shown),
and iNOS, IFNs, iNOS, and TNF-a
did not participate singularly in neutrophil
antiviral activity. Instead, inhibition of
FasL moderately inhibited antiviral func-tion, suggesting neutrophils restrict MCMV via expression of
TNFSF proteins.
Neutrophils receive activation signals during migration into
inflamed tissue (Futosi et al., 2013), suggesting their activation
in MCMV infection may be independent of virus recognition.
Indeed, TRAIL expression by neutrophils is rapidly induced by
IFNs (Koga et al., 2004; Tecchio et al., 2004). Although neutrali-
zation of individual IFNs did not abrogate anti-MCMV neutrophil
activity in vitro, it is possible that multiple antiviral cytokines
induce antiviral neutrophil activity in vivo without the requirement
for pattern recognition receptor-mediated neutrophil activation.
IL-22R expression determined the tissue-restricted influence
of IL-22 on antiviral immunity. However, neutrophil depletion in–483, April 9, 2014 ª2014 The Authors 479
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neutrophils, with no obvious role for neutrophils in splenic
MCMV infection. CXCL1 did not influence neutrophil accumula-
tion within the spleen. Differences in orchestration of splenic
versus pulmonary and hepatic neutrophil responses may influ-
ence their ability to counter MCMV. MCMV cell tropism within
different organs may also influence neutrophil antiviral control.
Stromal cells are targeted by MCMV in the spleen (Hsu et al.,
2009; Schneider et al., 2008; Verma et al., 2013), and respon-
siveness of these cells to effector molecules produced by
neutrophils may differ from infected cells in the liver and lung.
Moreover, the efficiency of viral evasion mechanisms may vary
in different cell types, influencing the efficacy of neutrophil
antiviral control. Importantly, however, neutrophil depletion in
RAG/ mice elevated splenic virus load, demonstrating that
neutrophils can limit MCMV infection in the spleen when present
in large numbers.
Given the antiviral role of neutrophils, it is surprising
that HCMV encodes a homolog of the neutrophil-attractant
chemokine CXCL1 (UL146), hypothesized to promote neutro-
phil recruitment to facilitate HCMV dissemination (Penfold
et al., 1999). Host survival in acute infection is essential for
establishment of virus persistence and dissemination. Thus,
neutrophil limitation of acute infection facilitated by UL146
may be a necessary evil to enable virus chronicity and
transmission. Alternatively, UL146 may act preferentially in
certain contexts, for example by promoting neutrophil adher-
ence to virus-infected vascular endothelium, but exert less
influence within peripheral organs where, as demonstrated in
MCMV infection, mammalian CXCL1 is expressed at bio-
logically significant levels. Importantly, MCMV did not produc-
tively replicate within neutrophils (Figure S4D). Moreover, we
detected very few neutrophils in the salivary glands at the
onset of virus persistence (data not shown), supporting the
hypothesis that monocytes rather than neutrophils disseminate
MCMV (Stoddart et al., 1994). Given that CXCL1 promotes
recruitment of nonneutrophils (Tsai et al., 2002), our data imply
that UL146 may have a function distinct from neutrophil
recruitment.
Of note, MCMV-infected IL-22R/ mice did not exhibit
heightened virus load, reduced neutrophil recruitment, or
CXCL1 protein in peripheral sites of infection (data not shown).
Numerous cytokines can induce proinflammatory chemokines,
and heightened proinflammatory cytokine and chemokine
responses have been reported following viral infection of
IL-22/mice (Guabiraba et al., 2013), suggesting that alternate
proinflammatory/antiviral mechanisms compensate for the
absence of the IL-22R signaling in knockout mice, whereas
such compensatory mechanisms are absent after IL-22 neutral-
ization in WT mice.
Although NK1.1 depletion revealed that NK and NK T cells
secrete virus-induced IL-22, concurrent depletion of NK cells
and neutrophils had an additive effect on elevating virus load.
Moreover, we observed no decrease in neutrophil recruitment
after NK cell depletion (data not shown). Although IL-22-produc-
ing T cells in part compensate for the absence of IL-22+NK1.1+
cells, MCMV itself is a potent inducer of CXCL1 secretion. This
suggests that high virus load after NK cell depletion not only
induces significant pathology (van Dommelen et al., 2006) but480 Cell Host & Microbe 15, 471–483, April 9, 2014 ª2014 The Authoalso is sufficient to promote neutrophil recruitment. Thus,
through interactions with the stromal compartment, NK cells
may promote controlled neutrophil recruitment by restricting
virus replication and inducing IL-22-dependent neutrophil-acti-
vating chemokines.
IL-22 neutralization in neutrophil-depleted mice failed to
further increase virus load, suggesting a dominant role of neutro-
phil recruitment in the antiviral activity of IL-22. However, our
study does not preclude the existence of additional antiviral
pathways elicited by IL-22R signaling. IL-22 exerts a vast range
of biological activities (Ouyang et al., 2011; Sonnenberg et al.,
2011; Zenewicz et al., 2007). Indeed, during HIV and influenza
infections, IL-22 limits epithelial cell damage atmucosal surfaces
(Kim et al., 2012; Kumar et al., 2013). Given the critical role of
mucosal surfaces in herpesvirus dissemination and pathogen-
esis, the role that IL-22 may play in acute and chronic infection
of the mucosa warrants further investigation.
In summary, we identify IL-22 as a critical antiviral effector
cytokine in peripheral sites of MCMV infection and identified
the recruitment of neutrophils as a mechanism through which
IL-22 affords antiviral protection. These data define neutrophils
as an important antiviral effector cell population that acts during
the initial stages of CMV infection and uncover the TRAIL/
TRAILR pathway as a mechanism through which neutrophils
exert antiviral control.
EXPERIMENTAL PROCEDURES
Mice, Viral Infections, and Treatments
All experiments were conducted under a UK Home Office project license (PPL
30/2442 and 30/2969). WT C57BL/6 mice were purchased (Harlan), RAG1/
mice were bred in-house, IL-22/ mice were kindly provided by Jean-Chris-
tophe Renauld (Ludwig Institute, Brussels), and IL-22RA1 reporter mice were
generated as described in the Supplemental Experimental Procedures.MCMV
Smith strain (ATCC) was prepared in BALB/c salivary glands and purified over
a sorbital gradient. Virus from homogenized organs and tissue culture super-
natants were titered on 3T3 cells. Micewere infected intraperitoneally (i.p.) with
3 3 104 pfu MCMV and weighed daily. Some mice were injected i.p. with
200 mg aNK1.1 (clone PK136, BioXCell) or IgG control on days 2, 0, and +2
p.i. For T cell depletion, mice were injected (i.p.) with 200 mg aCD4 antibody
(100 mg clone YTS191, 100 mg clone YTS3) and 200 mg aCD8 antibody
(100 mg clone YTS156, 100 mg clone YTS169, all in-house). Neutrophils were
depleted with 100 mg aLy6G (clone 1A8, BioXCell); for TRAIL neutralization
mice were administered 250 mg of aTRAIL (clone N2B2, Biolegend), and for
IL-22 neutralization mice were administered i.v. 50 mg goat IgG (Chemicon)
or aIL-22 (R&D Systems). Somemice were treated with 100 mg IgG or aCXCL1
(clone 124014, R&D Systems). All administrations were day 0 and, for 4-day
experiments, 2 p.i.
Flow Cytometry
Leukocytes were isolated from murine tissue as previously described (Stacey
et al., 2011) and stained with Live/Dead Fixable Aqua (Invitrogen), incubated
with Fc block (eBioscience), and stained for surface markers with a combina-
tion of antibodies listed in the Supplemental Experimental Procedures. To
detect IL-22-secreting cells, cells were incubated in brefeldin A (Sigma-
Aldrich) ± IL-23 (50 mg/ml, R&D Systems) ± 50 ng/ml PMA and 500 ng/ml
ionomycin (both Sigma-Aldrich) prior to surface staining and permeabilization
with saponin buffer, stained with aIL-22, aIFN-g, agranzyme B, and/or
aRORgT. To measure CD11b expression by neutrophils, tissues remained
on ice during processing and red blood cells were not lysed, to avoid cell
stimulation prior to staining. For TRAILR expression analysis, fibroblasts
were infected with MCMV at a moi of 0.2 and stained with aTRAILR (clone
5D5-1, eBioscience). Further details are provided in the Supplemental Exper-
imental Procedures.rs
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Excized lungs, livers, and spleens (50 mg) were weighed, washed in PBS,
and homogenized in DMEM. Supernatants were assayed for cytokines by
cytometric bead array (eBioscience) or, for IL-22 and CXCL1, ELISA (eBio-
science and R&DSystems, respectively). In some experiments, 3T3 fibroblasts
and SGC1 cells (determined by FACS to be IL-22R and IL-22R+, respectively,
data not shown) were infected with MCMV (moi 0.5) or treated with 50 ng/ml
IL-22 (R&D Systems) for 30 min prior to washing. CXCL1 protein was assayed
by ELISA after 6 hr.
Histological Analysis
To identify IL-22RA+ cells, tissue sections from WT and IL-22ra1-LacZ mice
were stained overnight in 0.1% (w/v) 5-bromo-4-chloro-3-indolyl-beta-D-
galactosidase (X-gal; Invitrogen), and reporter activity identified under light
microscopy (Zeiss Axiovert 200M) with AxioVision version 4.8.2 software.
Neutrophil colocalization was assessed in paraffin-embedded liver sections
stained with am123 and aLy6G and visualized with DAB (Vector Labs) and
VIP Chromogen solution (Vector Labs), respectively. Further details are in
the Supplemental Experimental Procedures.
Assessment of Gene Expression
RNA was extracted from tissue by RNA easy kit (QIAGEN), cDNA synthesized
with aTaqMan reverse transcription kit (AppliedBiosystems), andgeneexpres-
sion determined by quantitative PCR using a Mini Opticon (Bio-Rad) and Plat-
inum SYBR greenmastermix reagent (Biorad), using primers listed in Table S1.
Assessment of Neutrophil Antiviral Activity
Splenic neutrophils were purified from RAG/mice using a negative selection
kit (Stemcell technologies) and a positive selection kit (Miltenyi Biotec) as
described in the Supplemental Experimental Procedures, and incubated
with MCMV-infected 3T3s (moi 0.02). MCMV in supernatants was measured
7 days later by plaque assay. Freeze-thawed neutrophils were nonviable con-
trols. Some wells received inhibitory reagents: aTRAIL (10 mg/ml, clone N2B2,
Biolegend), aFasL (10 mg/ml, clone 101626, R&D Systems), aIFNa (10 mg/ml,
clone RMMA-1, PBL Interferon Source), aIFNb (10 mg/ml, clone RMMB-1,
PBL Interferon Source), aIFNg (10 mg/ml, clone XMG1.2, in house), aTNF-a
(10 mg/ml, XT22, in house), and iNOS inhibitors (10 mM, 1400W, Sigma-
Aldrich). Some MCMV-infected fibroblasts were treated with TRAIL or FAS
(R&D Systems) at concentrations stated in Figure 7.
Statistics
Statistical significance was determined using the Mann-Whitney U test (viral
load analysis) or the two-tailed Student’s t test (weight loss, flow cytometry,
ELISA); *p% 0.05, **p% 0.01, ***p% 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, one table, and Supplemental
Experimental Procedures and can be found with this article at http://dx.doi.
org/10.1016/j.chom.2014.03.003.
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